Page 1


W H AT G U I DE S U S – OU R CR E DO We believe our first responsibility is to the doctors, nurses and patients, to mothers and ­fathers and all others who use our products and services. In meeting their needs everything we do must be of high quality. We must constantly strive to reduce our costs in order to maintain reasonable prices. Customers’ orders must be serviced promptly and accurately. Our suppliers and distributors must have an opportunity to make a fair profit. We are responsible to our employees, the men and women who work with us throughout the world. Everyone must be considered as an indi­ vidual. We must respect their dignity and recognize their merit. They must have a sense of security in their jobs. Compensation must be fair and adequate, and working conditions clean, orderly and safe. We must be mindful of ways to help our employees fulfill their family responsibilities. Employees must feel free to make suggestions and complaints. There must be equal opportunity for employment, development and advancement for those qualified. We must provide competent management, and their actions must be just and ethical.

We are responsible to the communities in which we live and work and to the world community as well. We must be good citizens – support good works and charities and bear our fair share of taxes. We must encourage civic improvements and better health and education. We must maintain in good order the property we are privileged to use, protecting the environment and natural resources. Our final responsibility is to our stockholders. Business must make a sound profit. We must experiment with new ideas. Research must be carried on, innovative programs developed and mistakes paid for. New equipment must be purchased, new facilities provided and new products launched. Reserves must be created to provide for adverse times. When we operate according to these principles, the stockholders should realize a fair return.

Robert Wood Johnson, chairman from 1932 to 1963 and a member of the founding family, formulated this credo in 1943. Encouraged by Johnson & Johnson’s many years of suc­cess throughout the world, we shall continue to let this moral compass guide us in our daily work for many years to come.

47° 42’ 40.4” N 8° 38’ 23.8” E Hochstrasse 201 8200 Schaffhausen

Schaffhausen site

46° 56’ 7.6” N 7° 23’ 9.9” E Rehhagstrasse 79 3018 Bern

Bern site

47° 2’ 51.0” N 6° 44’ 36.7” E Chemin Blanc 38 2400 Le Locle

Le Locle site

47° 10’ 29.0” N 8° 30’ 50.9” E Gubelstrasse 34 6300 Zug

Zug site

47° 12’ 18.2” N 7° 32’ 48.9” E Luzernstrasse 21 A 4528 Zuchwil

Solothurn site

I N S W IT Z E R LAN D FO R A LL T H E WOR LD S I NCE 19 5 9 As the world’s largest healthcare company, Johnson & Johnson puts patients, doctors, nursing staff and customers first. Our products have been providing for greater quality of life throughout the world for more than 125 years. Johnson & Johnson stands for progress and reliability. We take responsibility for public welfare and help millions of people each year with innovative medicines and medical technology. The most important role in this respect is played by our employees. Since 1959 Johnson & Johnson has had a presence in Switzerland, where we now employ more than 6000 people. But long-standing, valuable partnerships have also been established with local businesses. This international company is the biggest and most important employer in many parts of the country.

In the following pages, we present the five biggest Johnson & Johnson sites in Switzerland. The photos underline how locally rooted and ­interconnected our sites are. They illustrate in concrete terms the way we collaborate with companies from the region: not only with partners from the engineering, technology and healthcare sectors, but also with vendors such as a laundry, a workshop for the disabled or a waste disposal company. Like the 130,000 employees of Johnson & Johnson worldwide, they also play an important part in our success.

VI S I ON F ROM S C HAF F H AU S E N ­B EC O M E S R EALIT Y It is more than 80 years ago now that Dr. Bernhard Joos returned to Schaffhausen after a long stay in the USA – bringing with him innovative ideas and a vision: to help people achieve a better quality of life with innovative medicines. In his father’s laboratory, the Swiss chemist began to research active substances. Success soon followed. In 1936, he founded Cilag (Chemisches Industrielles Laboratorium AG). The small company, which specialized in the production and distribution of pharmaceuticals and chemical products, launched various medicines on the market within a few years and enjoyed a phase of rapid expansion. After the end of the war in May 1945, Cilag also sold its products abroad. First site in Switzerland Cilag has been part of the Johnson & Johnson Family of Companies since 1959. Schaffhausen was the American company’s first site in Switzerland. By teaming up with Johnson & Johnson, Cilag gained access to extensive basic research as well as the opportunity for efficient specialization. After some major investments – especially in the 1990s – Cilag AG is now an important technology center for the company.

Products in use worldwide As part of Janssen, the pharmaceutical division of Johnson & Johnson, the Schaffhausen company assumes a strategically important role as a market launch and production site – especially in the therapeutic areas of immunology, oncology and neurology. Cutting-edge technology is used to produce a variety of pharmaceutical dosage forms and chemical active ingredients. Cilag also produces medical devices such as the so-called ASP Cellblocks and Sterrad cassettes. These products are used in hospitals and laboratories all over the world for the sterilization of medical and surgical equipment. Cilag AG is one of the most important pro­ ducers in Switzerland’s pharmaceutical industry. The company employs around 1100 people, ma­king it the biggest private sector employer in the Schaffhausen region.

SLADANA ZARKOVIC & HANS ULRICH FRITSCHI Team Leader and Administration, PFE/POC-V Cilag AG / Process Planning Industry Pharma, altra Schaffhausen

Every day, people in the altra workshop for the disabled pick and pack medicines from Cilag – they are not only reliable, but also get a lot of enjoyment out of their work. “This work is ideally suited to our people. They put their heart and soul into it”, says Hans Ulrich Fritschi. The pharmaceutical company Cilag has been heavily engaged in social activities for many years.

KATHRIN UNGER & FRANZ ROHNER Assistant Energy Industry, SH POWER / Manager Technical Services Electro and Calibration, Cilag AG

A large company like Cilag needs the best possible access to power, water and gas supplies. “SH POWER is always there when new concepts have to be developed and implemented”, says Kathrin Unger. The collaboration works perfectly – “even if we don’t always see eye to eye, for example on energy prices”, says Franz Rohner with a smile.

CHRIS NICHOLS & FRANCIS VAN DER EYCKEN Principal Scientist API Small Molecule Development, Cilag AG / Head of Innovation Departments RXE, Mettler Toledo International

Mettler Toledo knows exactly what Cilag needs. The specialist for precision instruments produces equipment that is tailored exactly to the chemistry laboratory. “Francis Van Der Eycken brings bags of enthusiasm to his work – you can really feel that in the quality of his products”, says Chris Nichols.

PAUL SIEBER & RUEDI RITZMANN Head of Facility Management, Operation Support Cilag AG / General Manager, Ritzmann Textilpflege AG

For more than 20 years, Ritzmann has laundered the clothes of Cilag, its biggest customer. More than 70 tons a year - from lab coats through protective overalls to shower towels and socks. “Ritzmann Textilpflege AG is more than just a partner”, says Paul Sieber. “The whole team is actively involved and provides us with constructive ideas.»

H I G H- P R ECI S ION DEVE LOP M E NT S F RO M LE LO CLE “It ought to be possible to use the high-precision engineering of the watch industry for medical purposes”, said Luc Tissot, CEO of Tissot at the end of the 70s. The watch industry was in the midst of a major crisis at the time. In 1983, Tissot founded Medos SA based in Le Locle. Soon afterwards, a small team around the Technical Director Jean-Jacques Desaules and Columbian neurosurgeon Salomón Hakim developed a programmable mini-implant for the treatment of hydrocephalus, also known as water on the brain. The mechanism of the so-called Hakim valve is still in use today all around the world. Cornerstone for further developments With its highly effective product for hydrocephalus therapy, Medos laid the cornerstone for further pioneering developments. Founded more than 30 years ago as a small startup, the medical technology company rapidly grew to become one of the most important pillars of the local economy. Medos has been part of the Johnson & Johnson Family of Companies since 1991. ­Today, Medos is a subsidiary of Medos Inter­ national, which is likewise headquartered in Le Locle and is of major importance for Johnson & Johnson as a center for research and development and also for production and trade.

Important role in the Canton of Neuchâtel Medos International provides local support for other companies such as Ethicon and for business lines of DePuy Synthes. The company and its subsidiaries manufacture, amongst other things, implants for neurosurgery and spine ­surgery and also implantable drug delivery systems, but it is also a leading producer of implants for sports medicine and of solutions for gynecology and wound management. Medos International is also a major supplier for various companies of Johnson & Johnson around the world and manages the global distribution and medical activities of the subsidiary companies. With around 1000 employees in Le Locle, Neuchâtel and La Chaux-de- Fonds, Medos International is one of the most important employers in the Canton of Neuchâtel.

CHRISTINE SCHERRER & PATRICK HAENNI Communication Coordinator DePuy Switzerland, Johnson & Johnson Neuchâtel / General Manager alfaset

“Social esteem is very important to us”, says Christine Scherrer. For years, people with mental or intellectual disabilities at the alfaset foundation have worked for DePuy. They print and sort the stationery or operating instructions and pack products. “This work has a real purpose and is a great motivation for our people”, explains Patrick Haenni.

PATRICK DUBOCHET & MARC-OLIVIER GUEISSAZ Sales Manager, Authorized Representative Ciposa SA / Manufacturing Engineering Manager MESciTech, DePuy Synthes

“Ciposa always comes up with a precise technical solution in no time�, says Marc-Olivier Gueissaz full of praise. The company specializes in modular high-tech systems and makes automated assembly or laser marking machines for the orthopedic and neurology specialist DePuy Synthes. With their work, the two companies give hope to people with disorders of the spine.

MELANIA PEGURRI & SARALA PADALA Customer Support, Sales, Synergy Health Däniken AG / Manager Sterilization and Microbiology, Quality Operations, Ethicon Sàrl

What binds these women is a gamma ray system: Synergy Health uses this system to irradiate and sterilize medical devices, such as dressings, for Ethicon – a small truckful every day. “Both sides are aware that human lives depend on our work, and so we take due care in what we do. It’s a model cooperative arrangement”, says Melania Pegurri.

FABIEN BOUDUBAN & MATHIEU EMONIN CEO and Owner, Tectri SA / Strategic Sourcing Specialist, Division Spine, DePuy Synthes

These partners provide reinforcement for injured spines: Tectri produces special parts such as titanium nuts and bolts for fixing the spinal column, which DePuy Synthes then packages and distributes worldwide. “The local proximity of Tectri means we can develop a lot of products together�, says Mathieu Emonin. This is an additional advantage of what in all other respects, too, is a good collaboration.

Z UG S IT E – WH E R E TH E F U TU R E B EG I N S In the mid-80s, Johnson & Johnson opened its first office in Zug with three employees. Since then the importance of the site has steadily grown. Today, thirty years later, Zug is one of the most important strategic hubs of Johnson & Johnson outside the USA. In 2013, the company moved into what is probably the most modern office building in Switzerland. At the site in Zug, around 900 people from more than 40 nations work in an open, inspiring atmosphere. For Johnson & Johnson, Zug is an important center for all three business areas, namely Consumer Health Care, Medical Devices & ­Diagnostics and Pharmaceuticals. From Central Switzerland, the company provides support for more than 100 markets in 17 currencies. From Zug out into the world Johnson & Johnson Consumer Europe, for example, is responsible for the supply of consumer goods to Europe, the Middle East and ­Africa. The Janssen Supply Group looks after the global distribution of the Pharmaceuticals division. LifeScan is a provider of blood glucose meters and of services for diabetes patients. And Animas produces insulin delivery products, as well as accessories and software, to allow ­diabetes patients a more flexible lifestyle.

A wide range of activities Swiss sales and marketing for Medical Devices & Diagnostics, consumer goods and over-thecounter medicines and also Pharmaceuticals are the responsibility of Johnson & Johnson AG, Consumer Health Care Switzerland and also Janssen-Cilag AG, which also looks after the Austrian market. The Campus Services department is responsible for a wide range of support activities – including Finance, IT Management, Human Resources and Administration for the numerous companies and divisions. Work models for the future Zug is an attractive business hub for international companies – added to which it enjoys good rail and road links to Zurich airport. The Johnson & Johnson site in Zug is considered a model for the way we will work in the future and offers perfect conditions for creativity and a fulfilling professional life.

MANÙELA K. ARNOLD & FELIX BURKHARD Commercial Director, Consumer Health Care Switzerland, Johnson & Johnson / Head of Retail, Galenica AG

“Some of our brands require individual consulting – the pharmacies of Galenica are very strong on this”, says Manùela K. Arnold explaining the good and long-standing partnership. The companies also share the same spirit of innovation and openness to new approaches. Galenica sells well-known Johnson & Johnson articles such as Imodium, Nicorette, Compeed and Neutrogena.

MARTIN FROMER & VANESSA MESGUICH MD, Associate Professor, Head of Arrhythmia Unit, Cardiology Service, University Hospital Lausanne / Senior Account Manager Biosense Webster, Johnson & Johnson AG

Biosense Webster is the developer of a magnetic 3D navigation system for the investigation of cardiac arrhythmias. The University Hospital Lausanne and Martin Fromer are among the first users of the system: “Thanks to the advanced technology of Biosense Webster, radiation exposure is much lower for patients and investigators alike – this is important for our work.»

MARKUS REINERT & ALEKSANDRS SIDORECS Head of Market Development International & License, Emmi International Ltd / Procurement EMEA Contract Manufacturing, Cilag GmbH International

Emmi produces 110 million little bottles of the yoghurt drink Benecol for Cilag every year. The drink helps to lower cholesterol levels. Markus Reinert values the cooperation for the lively exchange of ideas it generates: “As a pharmaceutical company, Cilag has very high ­quality standards – we have also learned a lot from this in the food sector.”

BEAT GAUDERON & YVONNE STARK Managing Director, bildxzug / HR Director Campus Zug, Cilag GmbH International

Well-qualified employees are essential for a company. bildxzug recruits and supervises commercial apprentices who get their practical training at Johnson & Johnson. For Beat Gauderon a very gratifying cooperation: “The apprentices can put the business English they learn with use to good use right away in this international company.�

R E S E A RCH I N B E R N K E E P I NG PACE W I TH T H E T I M E S Crucell Switzerland AG was founded in 1898 as the Swiss Serum and Vaccines Institute. In 2001, the organization changes its name and operated as Berna Biotech AG, which in turn was taken over in 2006 by the biotech company Crucell N.V. Since 2011, Crucell has been part of the Johnson & Johnson Family of Companies. The international company with headquarters in Leiden (Holland) is focused on the research, development, production and sale of ­innovative vaccines for the prevention of infectious diseases such as influenza, EHEC, meningitis B, HIV, RSV and polio. Fight against influenza At its site in Bern, a multifunctional project team is working on the development of a novel influenza vaccine. Influenza, or flu, is a highly infectious disease affecting the airways. The transmission of influenza viruses by droplet infection allows the flu to spread very rapidly in broad sections of the population. Outbreaks of flu occur every year, but vary considerably in severity.

Production in keeping with the times For decades, flu vaccines were produced by means of virus replication in incubated hen’s eggs. This production method is associated with a huge logistical effort, because millions of fertilized eggs have to be made available in good time every year. But a radical change is imminent: The production of flu vaccines has recently gone over to using cell culture methods for virus replication. The advantages of the cellbased method lie in the simpler production logistics, amongst other things. For example, in the event of a pandemic, production volumes can be quickly and flexibly adjusted. The use of live chick embryos for virus replication is also ­increasingly being called into question on the grounds of animal welfare. Intensive knowledge transfer The interplay between optimum vaccine strategy and the production method is a complex challenge. And it is one that the Crucell project team in Bern is always happy to confront anew. As part of the technology transfer, this know­ ledge also informs further projects in the Johnson & Johnson Group and thus positions the site in Bern as a flexible, reliable, quality-aware and cost-conscious development partner.

S O LOT H U R N S ET S S TAN DAR DS At the end of the 1950s, Swiss surgeons made headline news with a pioneering discovery. They proved that bone fractures of the arms and legs heal better with the use of surgical implants than using conventional methods. These doctors thus laid the cornerstone for the success story of the Solothurn company Synthes. Implants become standard In the 1970s, the company began with the production of implants for maxillofacial injuries and in the 1980s started to manufacture products for the spinal column. Soon the use of implants became standard in the treatment of bone fractures and other injuries.

Unique product portfolio In 2012, Johnson & Johnson acquired Synthes and merged it with DePuy. Today, DePuy Synthes is a global leader in medical technology. With the inclusion of Synthes in the Family of Companies, Johnson & Johnson expanded its unique product portfolio. DePuy Synthes specializes in joint replacements, neurosurgery, maxillofacial surgery, surgical power tools, reconstruction medicine and biomaterials such as implants that can be resorbed by the body. Several sites in Switzerland DePuy Synthes employs people in 60 countries. Eight of 14 production sites are located in Switzerland, including in the Solothurn and Baselland areas and also in Neuchâtel, in Ticino and in Valais. In total, there are more than 3000 specialists throughout Switzerland working in Research and Development, Production, Sales, Marketing, Supply Chain and other supporting functions. The Solothurn site also serves as headquarters for DePuy Synthes in Europe, ­Africa and the Near East.

Medical Devices & Diagnostics

WOR LD LEADE R I N TH R E E DI S C I P LI N E S The history of Johnson & Johnson is shaped by innovations that have proved themselves in more than 170 countries and have become ­indispensable for people throughout the world. The company is engaged in three business areas: Consumer Health Care, Medical Devices & Diagnostics and Pharmaceuticals. The product range includes consumer goods brands with a long tradition as well as special medical devices and highly effective medicines.

Medical Devices & Diagnostics In Medical Devices & Diagnostics, the Johnson & Johnson Family of Companies in Switzerland produces technologies for sophisticated medical procedures. The division is an international leader in almost all operational areas – for example in implants and suture materials. The portfolio of medical devices is based on a long tradition of quality and constant further development.

Consumer Health Care Personal hygiene products, cosmetics and overthe-counter medicines accompany people in Switzerland through their lives from birth to old age. These include, amongst other products, such well-known brands as Piz Buin, Compeed, Penaten and Nicorette. The trust that millions of customers place in our products is a daily obligation for Johnson & Johnson.

Pharmaceuticals The medicines of Johnson & Johnson Pharmaceuticals are helping patients all over the world. The most important therapeutic areas include cardiovascular and metabolic diseases, neu­ rology and pain, immunology, infectious diseases and vaccines, as well as oncology. The company has helped to make crucial strides in the treatment of many diseases with new products and innovative processes. Our research is shaped by tireless efforts to resolve the most important hitherto unanswered medical questions of our time.

Consumer Health Care

130 Y EAR S OF P R O G R E S S AN D I N NOVAT ION Founded in 1886 as a family business in New Brunswick (USA), Johnson & Johnson is one of the largest healthcare companies today, employing almost 130,000 people. Today, more than 250 subsidiary companies in 60 countries belong to the Family of Companies. For generations, Johnson & Johnson has developed products that improve the quality of life for people all over the world. Success with hygiene products The Johnson brothers from New Jersey recognized the need of doctors for reliable hygiene products as long as 130 years ago. Johnson & Johnson was the first company to launch sterile wound suture materials and dressings on the market. The success of the medical devices enabled the company to expand rapidly and to widen the product range – to include, for example, dental floss, sanitary pads and baby powder. These products soon found their way onto the market in Canada and the UK. The Medical und Pharmaceuticals divisions also found rapid success with medicinal products such as contraceptives and analgesics.

Credo since 1943 still applies In the 1940s Johnson & Johnson widened the product portfolio and expanded to Latin America and Africa, while at the same time starting operations in other European countries. Johnson & Johnson played an increasingly important role in medical progress and human health. Chairman of the Board Robert Wood Johnson was aware of this responsibility when, in 1943, he formulated the company credo, which remains valid to this day. In Switzerland since the 1950s In the decades that followed, Johnson & Johnson expanded its business further in Africa, Latin America and Asia and started to pursue a new growth strategy in Europe in the 1950s. At the same time, the American company also gained a foothold in Switzerland. In 1959, the company acquired the pharmaceutical manufacturer Cilag AG – an important milestone in the growth of the Pharmaceuticals division. Since then, Johnson & Johnson has continually expanded the site in Switzerland. Today, the company employs more than 6000 people in eight cantons.

Medical Devices & Diagnostics

E NGAG E D O U T OF C ONV ICT ION What makes a company strong? The maximum possible profit? Power and influence? No, it is the principles, the philosophy and the vision that make the character of a company. These values create trust among employees and consumers alike. “To look after the world – start with the individual” – it is on this principle that the social engagement of Johnson & Johnson is based in the most widely varying fields. Whether with the commitment to public welfare, in the support of social initiatives or with our engagement for the environment – our credo strengthens us in our resolve to take responsibility in society. For education and health Johnson & Johnson is engaged worldwide for people in situations of hardship and contributes to the improvement of health and education. In Switzerland, Johnson & Johnson is a member of associations and charitable organizations. The company also supports foundations that are committed to the welfare of people with ­disabilities.

For the benefit of people The employees of various Swiss sites regularly do voluntary work assignments on Community Days: In past years, for example, employees have helped out in a food assistance center, have looked after the residents of a retirement home and have taken on work in nature conservation areas. The Johnson & Johnson Family of Companies in Switzerland and the Johnson & Johnson Corporate Citizenship Trust are also involved in the project “Kinderpost for underserved communities” for the prevention of childhood accidents in families with a migration background. Lifescan and Cilag GmbH International support the Tour de Cure, a cycling tour around Lake Zug for the benefit of the Swiss Diabetes Society. These examples illustrate the commitment to public welfare which informs both the daily routine of our employees and our company as a whole and which is also reflected in our products and services.


R E S P ON S B I LIT Y ACROS S G E N E RAT ION S We are aware of our responsibility for the ­generations to come. At Johnson & Johnson, environmental protection and the health and safety of our employees play an important role. We have set ourselves the goal of going beyond the minimum standards required by law in all areas. In strategic planning we therefore make sure there is a balance between short and longterm objectives. To ensure that we are on the right track, we constantly review the key business performance data, optimize occupational safety and define measures to protect the environment. Sparing use of resources In the City Water Project, Johnson & Johnson has succeeded in dramatically reducing water consumption at the Schaffhausen site. A sophisticated, ultramodern system is used to cool the production plant today. The so-called closed loop recycles the water and plays a crucial part in ensuring that Johnson & Johnson manages with over 60 percent less drinking water in Schaffhausen today than in 2005.

Projects that serve as models In Neuchâtel, Johnson & Johnson is committed to the production of renewable energy. In Les Ponts-de-Martel, the company supports the gigantic solar energy installation on the roof of the ice-rink – supplying more than 35 households with sustainably produced power every year. Green is also the color of thinking at the site in Zug: The ecologically advanced infrastructure serves as a model. The greenproperty Gold, Minergie®-Eco seals of approval and the LEED (Leadership in Energy and Environmental Design) platinum certification confirm the sustainable construction of the buildings. Be healthy, stay healthy Johnson & Johnson is strongly committed to the health and safety of its employees. The ­basic principle is also reflected in the company credo. We not only carry out risk analyses and preventive care programs to assure the fully ­integrated protection of employees at the workplace. We also offer programs throughout the company that focus on promoting health in the areas of exercise, nutrition and stress management.

Consumer Health Care

G LO B AL JOB S – FUTU R E FOR ­TALE NT S Behind the success of Johnson & Johnson lie people. People who are forward-looking and want to get things done. The world’s largest healthcare company offers an international environment with unique career opportunities for young talents and experienced specialists. We support our employees with personal development programs and help them to achieve their objectives. Johnson & Johnson is considered one of the most attractive employees in Switzerland for specialists from a wide variety of professions. Besides engineers, chemists and pharmacists, Johnson & Johnson also employs specialists in the areas of Procurement, Finance, Supply Chain, Marketing, Sales and Management at its Swiss sites. Openly disclosing career wishes Open dialogue is an integral part of the cor­ porate culture. Just as we have been helping millions of people with innovative products for 125 years, so too are our employees crucially important to us. In the internal jobs database “My C ­ areer Opportunities” they can disclose their wishes openly at any time and get the ­latest i­nformation on global career opportunities. For Johnson & Johnson employs people worldwide and in those places where they can develop best. Johnson & Johnson fills half its vacancies with internal people: We create secure jobs and open the gates to the world for our employees.

Off to New York and Marketing It’s actually pure chance that she works in Marketing, says Nicole Fischer from Zug. After studying Economics at the University of St. Gallen, she completed an MBA at the Instituto de Empresa in Madrid. Everything pointed to a career in the financial sector – until a headhunter drew her attention to a job in Marketing with Johnson & Johnson in Zug. The numerous interesting brands and the opportunity to work both strategically and also close to the customer had been persuasive arguments in favor of the job. “The international environment also attracted me.” Nicole Fischer‘s first task at Johnson & Johnson consisted in building up marketing and distribution by wholesalers in Central and Eastern European markets. “I was able to have a say in everything from product positioning and pricing through marketing strategy to implementation in the marketplace”, says the 37-year-old. And her study of economics came in very handy, she adds. Nicole Fischer gained completely different glimpses into the company when she moved to Strategic Procurement. “The contact with vendors and agencies, the commercial responsibility and the strategic view of the whole value chain widened my horizon further”, she says. Today Nicole Fischer works at the Digital Center of Excellence in New York. Her team develops strategies on how to appeal to and involve cus-

“In New York I have my finger on the pulse of the times and have the opportunity to transfer know-how to Europe. At the same time, I bring European viewpoints to the discussion.�

New York, USA Nicole Fischer Today she works at the Digital Center of Excellence in New York, where she is designing social media strategies with her team. The mother of two has a university degree in Economics and an MBA. At Johnson & Johnson, Fischer initially worked in Marketing, and then in Strategic Procurement.

“We put the transfer of knowledge between the various units into practice – all around the world. This has opened up attractive career options for me.»

Beerse, Belgium Norbert Tröndle The qualified chemist Norbert Tröndle is Head of the Johnson & Johnson site at Helsingborg, Sweden, today. After working as Quality Assurance Manager in Schaffhausen, he moved to Puerto Rico to become Head of Product Launch. In Belgium he was a member of the Executive Committee.

tomers in this age of Facebook, Twitter and Google. “In New York I have my finger on the pulse of the times and have the opportunity to transfer know-how to Europe. At the same time, I bring European viewpoints to the discussion.”

employed by Cilag in Schaffhausen. He would also like to return there in the foreseeable ­future. But before that, a new challenge awaits him: Tröndle takes over as Head of Johnson & Johnson’s Swedish site in Helsingborg.

A chemist in the Caribbean When Norbert Tröndle enrolled at university in 1984 to study chemistry, nothing pointed to his career later taking him to Puerto Rico, Belgium and Sweden. On the contrary: The Austrian by birth, from Vienna, decided to study at the local university rather than studying abroad. “Chemists are rather settled and not known for international careers”, says the 46-year-old today. The fact that everything turned out the way it did has a lot to do with the philosophy of Johnson & Johnson. “We put the transfer of know­ ledge between the various units into practice – all around the world.” This opened up attractive career options for the father of two. Norbert Tröndle joined Johnson & Johnson 12 years ago: At the Schaffhausen company Cilag he started as a Quality Assurance Manager in the field of non-sterile products.

Finding talents and providing structured support Johnson & Johnson aspires to recruit the best specialists and to provide them with the relevant support. Here we set great store by a precisely structured process in which we regularly assess potential and performance together with the employees. From this we develop the Talent Road Map for the individual professional career. Our management team is also responsible for elaborating a succession plan. In this way we are building up a wide-ranging, global “pipeline of leaders”.

The professional environment and the structured processes at Johnson & Johnson impressed him from the outset. After three years in “Quality”, Norbert Tröndle moved within Cilag to Production where he became a Production Manager. In 2009 he sought a new challenge. When a vacancy arose for a Head of Product Launch in Gurabo (Puerto Rico), Norbert Tröndle and his family did not hesitate for a second. In the Caribbean country he gathered valuable experience, not only professionally, but also at the personal level. His assignment in Puerto Rico was for a fixed term and so after two years he returned to Europe. In Beerse (Belgium) in 2011 the chemist became a member of the Executive Committee responsible for Liquids ­ & Creams and the warehouse. At Johnson & Johnson, global mobility is precisely regulated: Formally, Norbert Tröndle is still

Under the motto “Health needs work for the ­future” Johnson & Johnson has set itself the goal of continuously working on the best solutions for its customers. For this we need you and your ideas. We are one of the biggest and most multi-­faceted Swiss employers and offer exceptional opportunities. Grab the chance.

A ST RONG TEAM FOR YOU Cilag AG Hochstrasse 201 8200 Schaffhausen T +41 52 630 91 11 F +41 52 630 94 44

Medos International Chemin Blanc 38 2400 Le Locle T +41 32 934 80 00 F +41 32 934 89 73

Concept and design Crafft Kommunikation AG, Zurich

Cilag GmbH International Gubelstrasse 34 6300 Zug T +41 58 231 50 50 F +41 58 231 50 51

Synthes GmbH Luzernstrasse 21 A 4528 Zuchwil T +41 32 720 40 60

Illustration 1 Kilo, Böckten

Crucell Switzerland AG Rehhagstrasse 79 3018 Bern T +41 31 980 61 11 F +41 31 980 67 75

Photography Markus Bertschi, Zurich Christian Hagemann, Berlin

Prepress / Printing n c ag, Urdorf Cover Mathieu Emonin (Strategic Sourcing Specialist, Division Spine, DePuy Synthes) and Fabien Bouduban (CEO and Owner, Tectri SA) at Tectri SA, Court, in the Bernese Jura.

JOJO Broch CH en 140813  
JOJO Broch CH en 140813